R E C O R P U S – The Future of Cancer Treatment

RECORPUS is a BioMed startup active in Organ Repair technology research on a diverse range of diseases, with main focus on cancer, working at the intersection of medicine, biology, physics, and engineering. RECORPUS challenges the prevailing paradigms regarding the origin, mechanism and treatment of cancer. Its founder discovered the developmental origin, i.e. the biophysical impetus of cancer initiation and growth and proposes a new and more logical explanation for the underlying cause or origin (genesis) of cancer. This finding has paved the way for an entirely new and more rational treatment strategy. Unlike existing cancer therapies that primarily address the consequences or symptoms of cancer, the proposed treatment targets and eliminates the underlying cause of cancer. This pioneering treatment concept, strategy, and technology holds the potential to not only revolutionize cancer treatment but also to reverse certain metabolic or infectious diseases and addresses specific aspects of aging. Furthermore, due to its foundation on existing technologies, the development of the proposed cancer treatment can be carried out within a relatively short time compared to other treatments currently in clinical trial. In fact, a proof of concept or clinical trial can be started right away using specific chemotherapeutic agents, with or without readily available equipment or surgery, for a gradual or more rapid response, respectively.